580 likes | 902 Views
RISKS of Travel to Developing Countries. Diarrhea 34% (ETEC causes 30-60% of these cases)Respiratory 26%Skin disorder 8
E N D
1. Travel and Tropical Medicine Roger Thomas, MD, Ph.D, CCFP. MRCGP
2. RISKS of Travel to Developing Countries Diarrhea 34%
(ETEC causes 30-60% of these cases)
Respiratory 26%
Skin disorder 8%
Acute mountain sickness 6%
Accident and injury 5%
Illness with fever 3%
3. Mortality from travel in developing world
50% is cardiovascular (older travelers with pre-existing cardiac condition), but rates are not increased by travel
In younger travelers injuries are main cause of death: accidental death rate in 15-44 year olds is 2-3 times domestic rate (MVA, scooters, drowning)
4. Traffic accidents worldwide 2004 1.7 million deaths, single major cause of death in males 15-45
> 750 US citizens die, > 25,000 injured annually on foreign roads, some are permanent residents abroad, (implying > 75 Canadians and > 2,500 accidents)
30 million injuries
Egypt, Kenya, India, S. Korea, Turkey, Morocco most dangerous
Advise do not drive at night, especially rural areas; do not drive motorbike or bike
5. OUTLINE Take a history
past medical history, medications, vaccinations
planned travel
unplanned excursions and sports
Bring childhood vaccinations up to date (MMR, polio, tetanus)
Vaccinations and medications needed for trip
Ask their understanding of risks; your advice
Print off CDC data and have them read and underline it
Malaria: prevention; diagnosis; treatment
Traveller’s diarrhea: prevention; diagnosis; treatment
Helminths 9. Other
6. Let’s begin with a 60 year old going to Peru and Ecuador PMH: HTN, hyperlipidemia, well controlled; never smoker
What are his/her travel plans?
Review CDC website cdc.gov
Identify risks and prescribe
7. 60 year old visiting Peru and Ecuador Update childhood vaccinations
Check for egg allergy if plan MMR, influenza, Yellow Fever vaccines
GI risk: cholera? typhoid? Bacterial diarrhea? Hepatitis? (Twinrix) Helminths?
Yellow Fever?
Malaria risks?
High altitude sickness risks? (he/she is going to 3,600 meters rapidly by plane, no slow ascent; risks begin above 2,400 meters)
PE from air travel (5/million)
8. 60 year old visiting Peru and Ecuador: Other risks? Helminths such as Amebiasis, echinococcus
American trypanosomiasis (Chagas’ disease)
Cutaneous and mucocutaneous Leishmaniasis
Paragonimiasis (oriental lung fluke)
Brucellosis
Bartonellosis (Oroya fever) on western slopes of Andes up to 3000 m
Louseborne typhus in mountainous areas of Peru
9. 28 year old veterinarian, visiting Malawi, South Africa, advising for WHO PMH: LMP 6 weeks ago, rising ?HcG titres, planning to be in Africa during 1st and 2nd trimesters
GI risks?
Malaria risks?
Rabies risks?
Risks to pregnancy?
10. Live-attenuated vaccines in pregnancy MMR and varicella are live-attenuated and contrandicated in pregnancy because of theoretical risk to fetus
However, no evidence of harm from inadvertent rubella vaccination
?226 pregnant females 1971- 1989 in US
caused subclinical infection in 1-2% of fetuses,
no evidence of congenital rubella
?Motherisk found no evidence of increased
rate of fetal malformations in 94 women
vaccinated with rubella 3 months before
conception or during pregnancy
11. Live-attenuated vaccines in pregnancy No evidence of harm from inadvertent varicella vaccination
? in 362 women vaccinated during pregnancy, no cases of congenital varicella
12. Vaccines in pregnancy No evidence of increased risk of adverse reactions, teratogenic or embryotoxic effects in pregnancy
All classes of maternal IgG transported across placenta, mostly in 3rd trimester
maternal IgG has half life of 3-4 weeks in infant, waning after 6-12 months of life.
Strong evidence of benefits of vaccines
13. Canadian Immunization Guide Advice for pregnancy Safe
? Influenza (good idea as pregnant women have 4 x hospitalisation rate for influenza compared to non-pregnant due to increased CVS volume, HR and O2 consumption)
? Diptheria/tetanus
? Polysaccharide meningococal vaccine (no evidence for conjugate vaccine)
? Salk poliomyelitis vaccine
14. Canadian Immunization Guide Advice for pregnancy No apparent risk, recommended in women at risk
? Hepatitis B
No apparent risk, consider in high-risk situations
? Hepatitis A
? Pneumococcal polysaccharide
?Cholera (no data)
?Typhoid (no data)
?Pertussis (no data)
? Live Japanese encephalitis (no data)
Contraindicated (unless high risk travel unavoidable)
? Yellow fever (6/million risk of visceral and 6/million risk of cerebral complications for all vaccinees)
15. Malaria Incubation: for Plasmodium falciparum: 7-14 days (up to 6 weeks)
Partial immunity from long-term residence is against erythrocytic stages and diminishes within 6-12 months of leaving endemic area
Clinical presentation: (clinical diagnosis is inaccurate as malaria is a great imitator; must do thick and thin films)
Prodrome of tiredness, malaise and aching in the back, joints and abdomen, anorexia and nausea and vomiting. Tender splenomegaly. Conjunctivae suffused. Patient febrile for 2-3 hours before paroxysm.
16. Malaria “Cold stage” of rigors (15-60 minutes):
? sudden feeling of cold and apprehension
? pulse rapid and low volume
? mild shivering turns into violent teeth
chattering and shaking of the whole body.
Patients try to cover themselves with
bedclothes
? core temperature is high but peripheral
vasoconstriction with skin cold and goose-
pimpled
17. Malaria “Hot stage” up to 104F (2-6 hours): (“Ague attack” resembles the “endotoxin reactions” of lobar pneumonia or pyelonephritis)
? restless, unbearably hot, throws off all the
bedclothes, excited
? severe throbbing headache, palpitations,
tachypnea, postural syncope
? may vomit
? may become confused, convulse
? skin dry flushed and burning
? splenomegaly may be detected first the first time in this stage
“sweating stage” (2-4 hours): temperature returns to normal and patient sleeps
18. WHO criteria for Severe malaria Identify patients with severe malaria for special treatment with one or more of:
Cerebral malaria
Respiratory distress
Severe normocytic anemia
Renal failure
Hyperparasitemia
Pulmonary edema
Hypoglycemia
Circulatory collapse
Spontaneous bleeding
Generalised convulsions
19. Cerebral malaria (encephalitis) impairment of consciousness or generalised convulsion followed by coma
high fever can cause irritability, obtundation, psychosis, and febrile convulsions (children) so urgently treat impairment of consciousness
may thrash or lie immobile with eyes open or have dysconjugate gaze
20. Cerebral malaria (encephalitis) brainstem signs:
? doll’s eyes (in children)
? may be decorticate (flexion of elbows and wrists, supination of the arm) suggests severe bilateral damage to the midbrain
? may be decerebrate (extension of wrists and elbows with pronation of the arms suggests damage to the midbrain or the caudal diencephalon)
21. Cerebral malaria (encephalitis) children may have subtle convulsions (nystagmoid eye movements, salivation, shallow irregular respirations, clonic movements of an eyebrow, finger, toe or mouth)
with excellent care mortality is 15-20%; death within hours for children
respiratory distress (compensation for metabolic acidosis), laboured breathing, intercostal recession, nasal flaring, accessory muscles of respiration)
22. Malarial Anemia (defined as < 5 g/dl): children with severe anemia usually have acidosis (deep Kussmaul breathing);
malarial anemia kills as many children as cerebral malaria (mortality = 5-15%; mortality from acidosis = 24%; mortality from severe anemia + acidosis = 35%)
also common in pregnant women
23. Jaundice and hypoglycemia in malaria Jaundice
1/3 of adults; associated with cerebral malaria, acute pulmonary edema
Hypoglycemia
Anxiety, breathlessness, lightheadedness, tachycardia, impairment of consciousness, seizures, abnormal posturing can be misinterpreted as due only to the malaria
Pregnant women:
? cell-mediated immunity is altered to favour survival of the fetus (more so in primigravidae), the placenta is heavily parasitized (the parasites adhere to chondriotin sulphate on the syncytiotrophoblast) The peripheral blood film may show no parasites
?risk is greatest for primigravidae in areas of unstable malaria
24. Chemoprophylaxis of malaria Causal prophylaxis: atovaquone and primaquin act on exo-erythrocytic cycle in liver
Schizontocides: atovaquone, mefloquine, chloroquine, doxycycline, proguanil act on intra-erythrocytic parasites
Terminal prophyaxis: Primaquine acts on latent hypnozoites in liver to prevent relapses in P Ovale and P vivax
25. Chemoprophylaxis of malaria Mefloquine PO (Begin 1 week before departure, continue 4 weeks after return)
62.5 mg weekly children 3 months – 5
years
125 mg weekly 6-8 years
187.5 mg 9-14 years
250 mg weekly adults
26. Chemoprophylaxis of malaria Doxycycline PO 1.5mg/kg daily. Do not use children < 12 years and pregnant or lactating women; can begin 2 days before enter malarious area
Pyrimethamine-dapsone (Malaquine) PO 1 tablet = 12.5 mg pyrimethamine + 100 mg dapsone
Ľ tablet weekly children 1-5 years
1/2 tablet weekly children 6-11 years
1 tablet weekly children >11 years and adults
27. Prevention of malaria Bednets & clothes impregnated with pyrethroids.
Cochrane review by Gamble (2006) found for 4 RCTs of treated nets vs. no nets a reduction in relative risks:
RR 95%CI
?placental malaria 0.79 0.63 to 0.98
?low birth weight 0.77 0.61 to 0.98
Avoid going out at night, wear long sleeves and long trousers (80% of bites on ankles)
Compliance with medication
28. Treatment of Malaria ARTEMISINS (halve parasite clearance time compared to quinine, but RCTs do not show reduction in mortality compared to quinine)
Uncomplicated disease: artesunate or artemether by mouth 4mg/kg x 3 days. Give each day in divided doses. Artesunate suppositories are easy to use. Use with second drug (e.g. mefloquine) to prevent recrudescence)
29. Treatment of Malaria Severe disease:
? Artesunate: 2.4 mg/kg IV or IM; then 1.2 mg/kg IM daily.
To make artesunate: dissolve 60 g in 0.6 ml of 5% NaHCO3,
dilute to 5 ml with 5% dextrose and give IV or IM.
? Artemether: Loading dose 3.2 mg/kg IM then maintenance 1.6
mg/kg IM. Do not give artemether IV, only orally, by suppository
or IM. [Complete the therapy with oral
sulfadoxine/pyrimethamine]
30. Treatment of Malaria QUININE
Uncomplicated disease: 10m/kg quinine SALT by mouth three times daily x 7 days. Once parasites eradicated, change to tetracycline 4mg/kg PO four times daily OR doxycycline 3mg/kg PO once daily
Severe disease: starting dose: 20mg/kg quinine SALT IV over 2-4 hours THEN 10mg/kg infused over 2 hours every 8 hours until tolerates oral medication (sulfadxine/pyrimethamine). [If given IM, dilute to 60mg/ml and split between sites if volume exceeds 5ml]
Give IV doses in 500ml of 5% glucose over 4 hours
Reduce rate if cardiac arrhythmias
Pregnant women: quinine is the drug of choice.
31. Falciparum strains adjust to antibiotic pressure Treatment of malaria must take into account local sensitivity to medications and shifts in parasite genome due to antibiotic pressure
Zongo (Lancet 2007) showed in children older than 6 months in a 28 day RCT in Burkina Faso that risk of recurrent malaria was:
amodiaquine + sulfadoxine-pyrimethamine 1.7% artemether-holofantrine 10.2%
32. Large family going to Mexico for daughter’s wedding. They are worried about getting traveller’s diarrhea Advise on risks, precautions and treatment
33. TRAVELERS’ DIARRHEA: PREVENTION Hand washing: 30 seconds with soap
Boil, cook or peel, eat when piping hot. Avoid salads, ice cubes, food vendors, cans cooled in water (probably from a stream), shellfish, undercooked seafood
? However, most travelers commit a food indiscretion within the first 72 hours due to being tempted by the sight of snacks, pre-paid buffets and the unavailability of hot food
?Studies of US naval ships abroad showed the more indiscretions ashore (salads, ice in drinks, food vendors … ) the more were on sick parade the next day with diarrhea.
34. TRAVELERS’ DIARRHEA: PREVENTION 3. Take a micropore filter. Cryptosporidium can pass through a 1 micropore filter, so needs subsequent halogenation
Chlorine is less effective in acid or alkaline or cool water, so lengthen contact time (2 hours for Giardia, 10 minutes for bacteria). Resistance to halogenation increases from bacteria, viruses, protozoan cysts, bacterial spores to parasitic ova and larvae
Potassium Permanganate to wash fruit and veg
Kettle to boil water (boiling for 1 minute kills even Cryptosporidium
35. TRAVELERS’ DIARRHEA: PREVENTION 6. Pepto-bismol: 2 tablets qid reduces risk by 65% (children > 3 years: 1 tablet qid)
? Indications: Prophylactic Pepto-bismol for a short trip: Consider if immunocompromised, HIV+, severe inflammatory bowel disease, renal failure, poorly controlled insulin dependent diabetes. Or of you are a conference speaker or a musical performer who must be well at a specific time.
? Contraindications:
(a) 2 tablets have the salicylate content of one 325 mg aspirin, so contraindicated if allergy to aspirin, bleeding disorder, taking warfarin, history of GI bleed.
(b) If taking doxycycline: Pepto-bismol inhibits absorption of doxycycline (an important anti-malarial).
36. TRAVELERS’ DIARRHEA: PREVENTION 7. Dukoral cholera vaccine: provides 60% cross-over protection against ETEC.
8. Antibiotics: considering side-effects, best to use antibiotics for treatment in the case of diarrhea rather than prophylaxis
37. DIAGNOSIS of TRAVELLER’s DIARRHEA On a 3 week trip the indiscreet traveler is most likely to get diarrhea in the first week, and will need guidance about self-treatment.
>60% is bacterial: Most common is E. Coli, then Shigella, Salmonella, Campylobacter
Attack rate remains same in long-term travelers and expatriates for several years
38. Diagnosis of Traveller’s Diarrhea by Clinical Presentation: Watery diarrhea (60%): Mostly enterotoxigenic E. Coli; also Salmonella, Campylobacter, Vibrios. Parasites such as Giardia, Cryptosporidium, Cyclospora and Isospora can cause watery diarrhea. 10% is viruses.
Symptoms last 3-5 days and range from several watery stools per day to more explosive profuse but non-bloody diarrhea. Some may have nausea, cramps, vomiting, low grade fever.
39. Diagnosis of Traveller’s Diarrhea by Clinical Presentation: Dysentery (15%): Usually Shigella. Other causes: Salmonella, Campylobacter, Yersinia, E. Coli serotype 0157:H7, more rarely amebiasis.
Symptoms: small volume stools with mucous, high fever, abdominal pain and tenderness, prostration, feeling of incomplete evacuation. Blood seen in only 50% of patients.
Treatment: Treat all bloody diarrhea with antibiotics; fluids to prevent dehydration.
40. Diagnosis of Traveller’s Diarrhea by Clinical Presentation: Chronic diarrhea, lasting > 1 month (3-5%): Usually Giardia or Campylobacter. In many cases tests are negative and is attributed to postinfectious lactose intolerance and IBS.
Symptoms: vague abdominal pain, bloating, nausea, weight loss, low grade fever.
41. Treatment of Diarrhea while Travelling
1. Oral rehydration
Severe dehydration:. WHO is glucose based, CeraLyte is rice based. If not available, make your own with 1 teaspoon salt and 2 tablespoons sugar or honey in 1 L water. Continue to drink even if vomiting.
Moderate: drink 3 L water/day, add soup + salty crackers, avoid dairy
Mild: infants - continue usual breast feeding/formula/ fluids
42. Treatment of Diarrhea while Travelling 2. Loperamide: 2 mg. capsules: two STAT then 1 capsule for every loose stool, max 16 mg/day reduces frequency of stools and duration of illness by 80% due to anti-motility and anti-secretory actions.
Young children are more susceptible to side effects: drowsiness, vomiting and paralytic ileus. Not approved for children < 2 years.
3. Pepto-bismol (do not exceed 16 tablets/day): reduces diarrhea by 50% because of anti-peristaltic and anti-secretary effects.
43. Treatment of Diarrhea while Travelling 4. Antibiotics: If copious or bloody stools, or fever.
? Ciprofloxacin 750 mg once or 500 mg bid. If unwell continue for a total of three days.
Resistance: 90% in Thailand, 50% Nepal, 40% Egypt
? Alternatives:
Levaquin 500 mg once or 500 mg daily x 3 days
Azithromycin 1000 mg once or 500 mg daily for 3
days (also effective against Shigella, Salmonella, E.
Coli, Campylobacter and typhoid fever. In Thailand
more effective against Campylobacter than
ciprofloxacin.
? Flagyl 250 mg tid x 5-7 days if you consider you may
have Giardia and cannot get medical help. Do not
use with alcohol.
44. Treatment of Diarrhea while Travelling Treat all bloody diarrhea with antibiotics.
Treat pregnant women with ciprofloxacin, best alternative is azithromycin.
Consider whether the rapid diarrhea is limiting antibiotic absorption.
45. Returning travellers: how many will have symptoms?
Which symptoms are most frequent?
46. Returned travellers Freedman’s (NEJM 2006) study of 17,353 ill returned travellers from 30 GeoSentinel sites in developing countries
per 1000 travellers
Systemic febrile illness 226
Acute diarrhea 222
Dermatologic disorder 170
Chronic diarrhea 113
Nondiarrheal GI disorder 82
Respiratory disorder 77
Death 1
47. Returned travellers: basic approach to diagnosis Detailed history of symptoms
if persistent fever malaria thick and thin films and repeat in 12-24 hours
Detailed history of itinerary and exposures
Careful physical exam
CBC, LFTs, creatinine, electrolytes (if had diarrhea) (hepatitis Ags and Abs as appropriate)
2 fresh stools
48. Investigation of prolonged diarrhea (> 14 days) 2 fresh stools for
Parasites: Giardia, Cyclospora, Cryptosporidium, Microsporidum, Entamoeba histolytica
Bacteria: Enteropathogenic E. Coli, Shigella, Salmonella, Aeromonas, enteroaggreagative E. Coli, noncholera Vibrios
If all tests negative, consider ciprofloxacin 500 mg tid x 5 days if not yet given, then flagyl 250 mg tid x 7 days
If diarrhea continues, sigmoidoscopy or upper GI endoscopy
A few patients progress to IBS after Campylobacter
49. Investigation of persistent fever without focal disease: Blood cultures Bacterial endocarditis
Bacterial sepsis
Bartonellosis
Brucellosis
Leptospirosis
Listeriosis
Meliodosis
Meningococcemia
typhoid
50. Investigation of persistent fever without focal disease: blood or CSF for parasites Babesiosis
borreliae
African and American trypanosomiasis
malaria
microfilariae
visceral leishmaniasis
loiasis
51. Investigation of persistent fever without focal disease: serology Cytomegalovirus
Epstein-Barr
viral hepatitis
Leptospirosis
Rickettsiae
viral hemorrhagic fevers
Dengue
syphilis
relapsing fever
toxoplasmosis
52. You are going to work as a physician in a SubSaharan country (Sudan) for 2 years; What can you contribute? Train health professionals
Be able to do and teach a safe C-section and vacuum delivery
Reduce infectious disease risks by public health interventions
Involve other experts in increasing food production in each household
Encourage an organisation to come in and start small loans to households to start businesses (Gramin banks)
53. Sudan: Infectious Diseases: Arthropod borne diseases malaria (except above 2600 m)
filariasis
onchocerciasis (river blindness)
cutaneous and mucocutaeous leishmaniasis
visceral leishmaniasis
trypanosomiasis (sleeping sickness)
relapsing fever
louse- flea- and tick-borns typhus
Tungiasis
viral hemorrhagic fevers (from mosquitoes,
ticks, sand flies)
Yellow Fever
54. Sudan: Food and water-borne infections helminths
bacterial diarrhea; typhoid
hepatitis A and E
hepatitis B
cholera
55. Sudan: Food and water-borne infections: Helminths Metazoa
Flat worms Round worms
(nematodes)
Cestodes Trematodes
(tape worms) (flukes)
56. Sudan: Food and water-borne infections: Helminths: nematodes (round worms) Ascaris lumbricoides
Trichuris trichiura
Enterobius vermicularis
Stronglyoides
Ancyclostoma duodenale
Necator americanus
Trichinella spiralis
Wucheria bancrofti
Loa loa
Onchocerca volvulus
57. Sudan: Food and water-borne infections: Helminths: Cestodes (tape worms) Taenia solium
Taenia saginata
Echinococcus granulosus
Echinococcus multilocularis
58. Sudan: Food and water-borne infections: Helminths: Trematodes (flukes) Schistosoma haematobium, mansoni and japonicum